Monosodium urate crystals dissolve and are eliminated from joints and soft tissues as serum uric acid levels drop below its saturating point (400 μmol/l). Time to crystal clearance relates to ...
If gout itself contributes an additional cardiovascular risk, is this effect explained by the inflammatory state caused by the deposition of monosodium urate crystals? During an acute attack of ...
Insight into the immunopathogenesis of crystal-induced ... in the management of gout attacks, or whether they can prevent such attacks if administered when urate-lowering drugs are initiated.
No gout attack has occurred since the sixth infusion ... Numerous negatively birefringent needle-shaped monosodium urate crystals are detected by compensated polarized-light microscopy (original ...
Gout is a prevalent metabolic disorder characterized by urate crystal accumulation in joints, leading to acute arthritis and tophi formation. Despite advancements in management, the incidence and ...
Colchicine for gout flare prophylaxis reduces the risk for cardiovascular events among patients initiating urate-lowering therapy, according to data published in The Lancet Rheumatology.